UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013594
Receipt number R000015881
Scientific Title Establishment of treatment regimen to eradicate H. pylori infection in patients who failed 1st-line and 2nd-line therapy.
Date of disclosure of the study information 2014/04/01
Last modified on 2020/04/06 13:41:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Establishment of treatment regimen to eradicate H. pylori infection in patients who failed 1st-line and 2nd-line therapy.

Acronym

Alternative eradicate therapy for H. pylori infection.

Scientific Title

Establishment of treatment regimen to eradicate H. pylori infection in patients who failed 1st-line and 2nd-line therapy.

Scientific Title:Acronym

Alternative eradicate therapy for H. pylori infection.

Region

Japan


Condition

Condition

Helicobacter pylori-associated gastritis

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Establish a treatment regimen to eradicate H. pylori infection in patients who failed conventional therapy.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

eradication rate

Key secondary outcomes

side effects


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Treat the patients who failed conventinal eradication therapy using sitafloxasin containing regimen

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

patients who was diagnosed as infected-with H. pylori

Key exclusion criteria

who did not agree

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Shinsaku
Middle name
Last name Fukuda

Organization

Hirosaki University Graduate School of Medicine

Division name

Gastroenterology

Zip code

036-8562

Address

5 Zaifu-cho, Hirosaki

TEL

0172-39-5053

Email

tsimo_hki@hotmail.com


Public contact

Name of contact person

1st name Tadashi
Middle name
Last name Shimoyama

Organization

Hirosaki University Graduate School of Medicine

Division name

Gastroenterology

Zip code

036-8562

Address

5 Zaifu-cho, Hirosaki

TEL

0172-39-5053

Homepage URL


Email

tsimo@hirosaki-u.ac.jp


Sponsor or person

Institute

Hirosaki University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Hirosaki University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hirosaki University Graduate School of Medicine

Address

5 Zaifu-cho, Hirosaki 06-8562, Japan

Tel

0172-39-5053

Email

tsimo@hirosaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

弘前大学医学部付属病院


Other administrative information

Date of disclosure of the study information

2014 Year 04 Month 01 Day


Related information

URL releasing protocol

https://onlinelibrary.wiley.com/journal/15235378

Publication of results

Unpublished


Result

URL related to results and publications

https://onlinelibrary.wiley.com/journal/15235378

Number of participants that the trial has enrolled

50

Results

The eradication rate of PCAB-AMOX-STFX was 85.7% (42/49; 95% CI, 75.9-95.5%) by intention-to-treat analysis and 87.5% (42/48; 78.4-96.9%) by per protocol analysis. Eradication was unsuccessful in one of two patients whose strains had low sensitivity to AMOX and three patients whose strains were resistant to STFX In contrast, eradication therapy was successful in 13 patients infected with strains which were sensitive to both AMOX and STFX.

Results date posted

2020 Year 04 Month 06 Day

Results Delayed

Delay expected

Results Delay Reason

not accepted.

Date of the first journal publication of results


Baseline Characteristics

H. pylori-positive patients who had failed both first-line therapy (PPI or VPZ + AMOX + clarithromycin) and second-line therapy (PPI or VPZ + AMOX + metronidazole) were enrolled into the study.

Participant flow

Prior to the third-line therapy, patients underwent endoscopy to obtain H. pylori strains to test the susceptibility to antibiotics if they agreed.

Adverse events

None.

Outcome measures

The eradication rate of PCAB-AMOX-STFX was 85.7% (42/49; 95% CI, 75.9-95.5%) by intention-to-treat analysis and 87.5% (42/48; 78.4-96.9%) by per protocol analysis. H. pylori was isolated from 19 patients before starting the triple therapy of PCAB, AMOX and STFX. Eradication was unsuccessful in one of two patients whose strains had low sensitivity to AMOX. In contrast, eradication therapy was successful in 13 patients infected with strains which were sensitive to both AMOX and STFX.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 07 Month 09 Day

Date of IRB

2013 Year 09 Month 01 Day

Anticipated trial start date

2013 Year 09 Month 01 Day

Last follow-up date

2017 Year 09 Month 30 Day

Date of closure to data entry

2017 Year 12 Month 30 Day

Date trial data considered complete

2017 Year 12 Month 30 Day

Date analysis concluded

2018 Year 09 Month 30 Day


Other

Other related information



Management information

Registered date

2014 Year 04 Month 01 Day

Last modified on

2020 Year 04 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015881


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name